Vontobel Holding Ltd. Takes $226,000 Position in Tempus AI, Inc. (NASDAQ:TEM)

Vontobel Holding Ltd. bought a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 4,684 shares of the company's stock, valued at approximately $226,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Victory Capital Management Inc. acquired a new position in shares of Tempus AI during the fourth quarter valued at $216,000. Wells Fargo & Company MN boosted its holdings in shares of Tempus AI by 13.2% during the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock valued at $80,000 after acquiring an additional 278 shares during the period. SeaCrest Wealth Management LLC acquired a new position in shares of Tempus AI during the first quarter valued at $535,000. Sumitomo Mitsui Trust Group Inc. boosted its holdings in shares of Tempus AI by 31.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after acquiring an additional 1,016,384 shares during the period. Finally, Cambridge Investment Research Advisors Inc. acquired a new position in shares of Tempus AI during the first quarter valued at $1,019,000. Institutional investors own 24.22% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on TEM. Needham & Company LLC reissued a "buy" rating and set a $70.00 price target on shares of Tempus AI in a report on Wednesday, May 7th. Morgan Stanley boosted their price target on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Piper Sandler boosted their price target on shares of Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a report on Thursday, May 15th. Bank of America upped their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. Finally, BTIG Research began coverage on shares of Tempus AI in a report on Monday, April 21st. They issued a "buy" rating and a $60.00 price objective for the company. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, Tempus AI has a consensus rating of "Moderate Buy" and an average target price of $65.09.

Insider Transactions at Tempus AI

In other Tempus AI news, EVP Erik Phelps sold 51,317 shares of the business's stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the sale, the executive vice president owned 97,779 shares in the company, valued at approximately $7,094,844.24. The trade was a 34.42% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jennifer A. Doudna sold 625 shares of the business's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $62.52, for a total value of $39,075.00. Following the sale, the director owned 26,554 shares in the company, valued at approximately $1,660,156.08. The trade was a 2.30% decrease in their position. The disclosure for this sale can be found here. Insiders sold 612,522 shares of company stock valued at $41,600,238 in the last quarter. 27.60% of the stock is owned by company insiders.

Tempus AI Price Performance

Tempus AI stock traded down $2.72 during midday trading on Friday, hitting $56.88. The company's stock had a trading volume of 8,009,649 shares, compared to its average volume of 7,547,042. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.71 and a quick ratio of 1.56. The stock's 50-day moving average price is $62.98 and its 200-day moving average price is $54.94. Tempus AI, Inc. has a 12 month low of $31.36 and a 12 month high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The firm had revenue of $255.74 million for the quarter, compared to analysts' expectations of $248.13 million. Tempus AI's revenue for the quarter was up 75.4% on a year-over-year basis. Sell-side analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.